Quick Takeaways
- Nantahala Capital Partners Limited Partnership filed SCHEDULE 13G/A for Senti Biosciences, Inc. Common stock, par value $0.0001 per share (SNTI).
- Disclosed ownership: 1.9%.
- Date of event: 31 Mar 2025.
Nantahala Capital Partners Limited Partnership - 31 Mar 2025 SCHEDULE 13G/A Report for Senti Biosciences, Inc. Common stock, par value $0.0001 per share (SNTI)
- Filing Manager
- Nantahala Capital Partners Limited Partnership
- Reporting Manager
- NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP
- Symbol
- SNTI
- Shares outstanding
- 26,447,368 shares
- Disclosed Ownership
- 502,500 shares
- Ownership
- 1.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 16:43:33 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Nantahala Capital Partners Limited Partnership disclosed 1.9% ownership in Senti Biosciences, Inc. Common stock, par value $0.0001 per share (SNTI) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 15 May 2025, 16:43.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 1.9% | 502,500 | 0 | 502,500 | /s/ Taki Vasilakis | Taki Vasilakis / Chief Compliance Officer Nantahala Capital Management, LLC |